The quantitatative distribution of the total donors for years was as follows: 19593 were positive for HBV, 78 (0.39%) were positive for HCV, and one was positive for HIV. Of the 15202 blood samples investigated during the second year, 230 (1.51%) were positive for HBV and 43 (0.28%) were positive for HCV. Of the 10187 blood samples investigated during the third year, 110 (1.07%) were positive for HBV, and 38 (0.37%) were positive for HCV. No blood samples were positive for HIV during the second and third years of the study period (Table) . There was no statistical signiÞ cant difference between the data of the HBV positivity rates and the years, and the HCV positivity rates and the years according to Spearman's correlation coefÞ cient (P = 0.667).
Transfusion of blood and blood product is a life saving measure and beneÞ ts numerous patients worldwide. However, transfusion-transmitted infections (TTIs) are the most commonly encountered complications in transfusion practice. Serological markers for hepatitis HBV, HCV and HIV are screened in blood banks routinely. These tests are obligatory for transfusion safety and may give an idea about the seropositivity rates of a speciÞ c region. In our study, the average mean of the three years was found to be 1.38% for HBV. The HBsAg positivity rates were found as 3.4% in Georgia in year 2001, 1.5% in Kingdom of Saudi Arabia in year 2002, 4.3% in Egypt, and 2.21% in Pakistan in year 2006. [2] [3] [4] [5] When we reviewed the same regions for HCV, the anti-HCV positivity rate was found to be 6.9%, 0.4%, 2.7% and 0.5%. [2] [3] [4] [5] Therefore, the results of our study seem to correlate or are lower than the rates in other countries.
We determined anti-HIV positivity in three individuals whose sera were tested by the MEIA method during three years study period, and only one serum was found to be positive after HIV conÞ rmation test.
There is no screening method to reduce the risk of TTIs to zero, it appears that it is essential to adopt strict criteria in the selection of donors and to avoid unnecessary transfusion. The prevalence of TTIs is much higher in higher risk group. We believe that the upgraded measures taken in the blood banks, the rising awareness in the public, the increased HBV vaccination rates, and the use of more developed technologies for determination of TTIs were responsible for the decrease of infection rates in blood banks. The number of samples included in our study has shown decrease during subsequent years. Ministry of health has streamlined the Red Crescent, which is a general blood source unit. It is more active and uses safe blood products. Consequently, the routine number of blood donations has decreased in our blood bank. In conclusion, there is no statistical difference in TTIs prevalence during the last three years in our blood bank. The data of our hospital's blood bank gives a lower rate of positivity for TTIs when compared with the prevalence of TTIs in other regions of our country and other countries.
STUDY OF HIV SEROPREVALENCE AND SOCIODEMOGRAPHIC PATTERNS IN ANTENATAL CASES AND VERTICAL TRANSMISSION TO NEONATES
Dear editor, The number of people living with HIV has been increasing in every region. With 27 million pregnancies a year and an overall estimated 0.3% prevalence rate of HIV infection among pregnant women, it is estimated that about 100,000 HIV infected women deliver every year. [1] Using a conservative vertical transmission rate of 30% about 30,000 infants acquire HIV infection each year. In Maharashatra HIV seroprevalence is >1% in women attending antenatal clinics. [2] This study conducted in a general public hospital for a period of one year, from October 2001 to September 2002, aimed at screening of antenatal mothers to Þ nd HIV seroprevalence, sociodemographic patterns in HIV seropositive mothers and reverse transcriptase PCR positivity in babies born of HIV positive mothers during Þ rst week of the birth. All pregnant women attending the antenatal clinics were screened for HIV sero-prevalence as per NACO guidelines. Reverse Transcriptase PCR (RT PCR) was done on neonatal serum samples, collected during Þ rst Þ ve days of birth and the test done as per instructions of the manufacturer.
During the study period, 2550 pregnant women were screened for HIV and 1.86% (52) were found to be HIV seropositive. Of these 52 seropositive women, 47 gave consent for the HIV testing of their babies which were included in further studies. The average age of these women was 23.78 ± 3.75 years. Out of these 47 women, 76.6% were residing in slums and 25.5% comprised of migratory population. Among the seropositive women 42.6% had education till secondary level, while 38.3% were illiterate and 19.1% had primary education. In this study, 57.4% of the spouses were unskilled worker followed by 19.1% in service, 12.8% factory workers and 10.6% were drivers/ cleaners. Primigravida women were 53.2% and 34% were second gravida. Of the 47 families, 93% were from low socio-economic class.
The mean time of collection of blood of the newborn was 2.85 days. There is no precise data available on the percentage of infants infected at birth. [3] The RT PCR done on the neonatal sera samples was positive for 31.9% (15) babies indicating probable in utero transmission of HIV infection. Follow-up RT PCR is needed to conÞ rm the transmission of HIV infection in these neonates. Among the women delivered by caesarean section, the rate of RT PCR positivity in infants was higher (10/16) than women who
